Jack Meehan
Stock Analyst at Barclays
(3.08)
# 1,250
Out of 4,944 analysts
136
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $250 → $275 | $272.54 | +0.90% | 16 | Jun 25, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $120.29 | +3.92% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $296.83 | -2.97% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $13.07 | +152.49% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $101.11 | +221.43% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.65 | +29.69% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $179.04 | -44.71% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $176.29 | +2.10% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $5.87 | +70.36% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $190.23 | -12.74% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $68.98 | -37.66% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $155.00 | -0.65% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $287.16 | +49.74% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $271.71 | +58.26% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $27.08 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $34.54 | +38.97% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,324.06 | -48.64% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $95.91 | -68.72% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $484.79 | -38.12% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.64 | +2,339.02% | 1 | Dec 11, 2017 |
Labcorp Holdings
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $250 → $275
Current: $272.54
Upside: +0.90%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $120.29
Upside: +3.92%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $296.83
Upside: -2.97%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $13.07
Upside: +152.49%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $101.11
Upside: +221.43%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.65
Upside: +29.69%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $179.04
Upside: -44.71%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $176.29
Upside: +2.10%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $5.87
Upside: +70.36%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $190.23
Upside: -12.74%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $68.98
Upside: -37.66%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $155.00
Upside: -0.65%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $287.16
Upside: +49.74%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $271.71
Upside: +58.26%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $27.08
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $34.54
Upside: +38.97%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,324.06
Upside: -48.64%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $95.91
Upside: -68.72%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $484.79
Upside: -38.12%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.64
Upside: +2,339.02%